PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575744
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1575744
Global Tylosin Market - 2024-2031
Overview
Global Tylosin Market reached US$ 440 million in 2023 and is expected to reach US$ 605 million by 2031, growing at a CAGR of 3.9% during the forecast period 2024-2031.
Tylosin is a macrolide antibiotic used in veterinary medicine to treat bacterial infections in livestock, including cattle, pigs, and poultry. It is effective against gram-positive and some gram-negative bacteria and mycoplasma species. Tylosin is used for respiratory, mastitis, and digestive system infections, and is valued for its anti-inflammatory properties and growth promotion. However, its use in food-producing animals is regulated to prevent antibiotic resistance.
Market Dynamics: Drivers & Restraints
Rise in demand for meat and animal based products
One key driver of the global tylosin market is the rising demand for meat and animal-based products, particularly in emerging economies. As global populations grow and incomes rise, especially in countries like China and India, there is an increasing demand for protein-rich diets, which in turn boosts the livestock industry. To maintain the health and productivity of livestock, Tylosin is commonly used to treat bacterial infections and promote animal growth. This heightened need for efficient livestock management and disease control to meet the rising demand for meat has significantly contributed to the growth of the Tylosin market.
Complications associated with tylosin
The side effects associated with the use of tylosin, such as diarrhea, vomiting, and gastrointestinal disturbances, are another factor limiting the market growth. The increasing awareness about the potential health risks associated with the use of antibiotics in animals is also expected to hamper the market growth.
Segment Analysis
The global tylosin market is segmented based on drug type, application, route of administration, end user and region.
The tylosin tartrate from the drug type segment accounted for approximately 41.3% of the tylosin market share
The tylosin tartrate from the drug type segment accounted for approximately 41.3%. Tylosin Tartrate is a widely used antibiotic due to its water-soluble properties, making it convenient for treating large groups of animals like poultry, swine, and cattle. It is effective in combating respiratory infections, mycoplasma, and gastrointestinal diseases. Its ease of administration and rapid absorption in animals make it a popular choice in the veterinary industry. As livestock farming expands globally, particularly in regions focused on mass animal production, the demand for Tylosin Tartrate remains strong.
Geographical Analysis
North America is estimated to hold about 41.04% of the total market share throughout the forecast period
North America is estimated to hold about 41.04% of the total market share throughout the forecast period due to presence of leading pharmaceutical companies focusing on animal health. Additionally, stringent regulations governing antibiotic usage in animal husbandry contribute to the adoption of tylosin-based products in this region.
Moreover, North American Tylosin market is a significant global segment, driven by the US and Canada's established livestock and poultry industries. The high demand for meat and dairy products has led to increased livestock farming, requiring effective veterinary antibiotics like Tylosin. Tylosin is widely used to prevent and treat bacterial infections in animals and improve growth rates, but its use is increasingly regulated due to concerns over antibiotic resistance.
Market Segmentation
By Drug Type
- Tylosin Tartrate
- Tylosin Phosphate
- Tylosin Base
- Others
By Application
- Felines
- Canines
- Livestock
- Others
By Route of Administration
- Oral
- Injectable
By End-User
- Veterinary Clinics
- Livestock Farms
- Animal Feed Manufacturers
- Pharmaceutical Companies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Competitive Landscape
The major global players in the market include Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, Elanco Animal Health, Apeloa Kangyu, Top Pharm Chemical Group among others.
Why Purchase the Report?
- To visualize the global tylosin market segmentation based on drug type, application, route of administration, end user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of the tylosin market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global tylosin market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2023
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
Table of Contents
1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
- 3.1. Snippet by Drug Type
- 3.2. Snippet by Application
- 3.3. Snippet by Route of Administration
- 3.4. Snippet by End User
- 3.5. Snippet by Region
4. Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Rise in demand for meat and animal-based products
- 4.1.1.2. Prevalence of bacterial infections in animals
- 4.1.2. Restraints
- 4.1.2.1. Complications associated with tylosin
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 4.1.1. Drivers
5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. Patent Analysis
- 5.6. PESTLE Analysis
- 5.7. SWOT Analysis
- 5.8. DMI Opinion
6. By Drug Type
- 6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
- 6.1.2. Market Attractiveness Index, By Drug Type
- 6.2. Tylosin Tartrate*
- 6.2.1. Introduction
- 6.3. Tylosin Phosphate
- 6.4. Tylosin Base
- 6.5. Others
7. By Application
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.2. Market Attractiveness Index, By Application
- 7.3. Felines*
- 7.3.1. Introduction
- 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.4. Canines
- 7.5. Livestock
- 7.6. Others
8. By Route of Administration
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 8.1.2. Market Attractiveness Index, By Application
- 8.2. Oral*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Injectable
9. By End User
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
- 9.2. Veterinary Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Livestock Farms
- 9.4. Animal Feed Manufacturers
- 9.5. Pharmaceutical Companies
10. By Region
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
- 10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.2.7.1. U.S.
- 10.2.7.2. Canada
- 10.2.7.3. Mexico
- 10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.3.7.1. Germany
- 10.3.7.2. UK
- 10.3.7.3. France
- 10.3.7.4. Italy
- 10.3.7.5. Spain
- 10.3.7.6. Rest of Europe
- 10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.7.1. Brazil
- 10.4.7.2. Argentina
- 10.4.7.3. Rest of South America
- 10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.7.1. China
- 10.5.7.2. India
- 10.5.7.3. Japan
- 10.5.7.4. South Korea
- 10.5.7.5. Rest of Asia-Pacific
- 10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
- 11.1. Competitive Scenario
- 11.2. Market Positioning/Share Analysis
- 11.3. Mergers and Acquisitions Analysis
12. Company Profiles
- 12.1. Zoetis*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
- 12.2. Tairui Pharmaceuticals
- 12.3. Lukang Pharmaceutical
- 12.4. Henan Hualun
- 12.5. Qilu Pharmaceutical (Inner Mongolia) Co., Ltd
- 12.6. Huvepharma
- 12.7. AdvaCare Pharma
- 12.8. Elanco Animal Health
- 12.9. Apeloa Kangyu
- 12.10. Top Pharm Chemical Group
LIST NOT EXHAUSTIVE
13. Appendix
- 13.1. About Us and Services
- 13.2. Contact Us
